BLINATUMOMAB
Clinical trials for BLINATUMOMAB explained in plain language.
Never miss a new study
Get alerted when new BLINATUMOMAB trials appear
Sign up with your email to follow new studies for BLINATUMOMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: dual attack trial begins
Disease control Not yet recruitingThis early-stage study aims to find a safe and effective dose of two drugs, revumenib and blinatumomab, given together for adults with a specific genetic type of acute lymphoblastic leukemia (ALL). It will enroll about 20 adults, including those newly diagnosed and those whose ca…
Matched conditions: BLINATUMOMAB
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo tested for Tough-to-Treat leukemia
Disease control Not yet recruitingThis study is testing if a new combination of two drugs, given as an injection and a pill, can help control a specific type of aggressive blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). It will involve about 60 adults, either newly diagnos…
Matched conditions: BLINATUMOMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New injection aims to stop Leukemia's return
Disease control Not yet recruitingThis study is testing whether giving the drug blinatumomab as an injection under the skin can help control very low levels of leukemia cells and prevent the cancer from coming back. It will involve about 40 adults with B-cell acute lymphoblastic leukemia who are in remission but …
Matched conditions: BLINATUMOMAB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC